Skip to content

Effect of Transfusion of Plasma on Endothelial During Liver Transplantation

Effect of Transfusion of Plasma During Orthotopic Liver Transplantation on Endothelial Glycocalyx Layer and Short-term Outcome in Patients With End-Stage Liver Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04107883
Enrollment
30
Registered
2019-09-27
Start date
2023-10-01
Completion date
2024-12-31
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Liver DIsease, Liver Transplantation

Keywords

endothelial, plasma

Brief summary

To study the effects of plasma transfusionon during liver transplantation on endothelial condition and short-term outcome in patients with end-stage liver disease.

Interventions

BIOLOGICALfresh frozen plasma

perform plasma transfusion in different phases during perioperation

DIAGNOSTIC_TESTblood sample

get blood samples at several specific points in time during perioperation

Sponsors

Beijing Chao Yang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Child A/B cirrhosis * patients who undergo the first OLT * Informed and consented * complete follow-up * cooperate with treatment

Exclusion criteria

* re-transplant * combined liver and other organ transplantation * BMI≥30Kg/m2 * patients with hypertension, diabetes, coronary heart disease, chronic renal insufficiency, preoperative pulmonary infection, pleural effusion * acute liver failure

Design outcomes

Primary

MeasureTime frameDescription
endothelial glycocalyx layer shedding markers24 hoursplasma concentration of endothelial glycocalyx layer shedding markers

Secondary

MeasureTime frameDescription
inflammatory cytokines24 hourslevels of inflammatory cytokines

Countries

China

Contacts

Primary ContactXun Liu
13466505725@163.com+86 13466505725
Backup ContactAnshi Wu
wuanshi@hotmail.com+86 010 85231330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026